Literature DB >> 30537371

Genotype and phenotype correlations for SHANK3 de novo mutations in neurodevelopmental disorders.

Ying Li1, Xiangbin Jia1, Huidan Wu1, Guanglei Xun2, Jianjun Ou3, Qiumeng Zhang1, Honghui Li4, Ting Bai1, Zhengmao Hu1, Xiaobing Zou5, Kun Xia1,6, Hui Guo1.   

Abstract

SHANK3 has been identified as the causative gene of 22q13.3 microdeletion syndrome phenotype. De novo mutations (DNMs) of SHANK3 were subsequently identified in patients with several neurodevelopmental disorders, including autism spectrum disorders (ASDs), schizophrenia (SCZ), a Rett syndrome-like phenotype, and intellectual disability (ID). Although broad developmental phenotypes of these patients have been described in single studies, few studies have reviewed the genotype and phenotype relationships using a relatively large cohort of patients with SHANK3 DNMs. In this study, we identified a de novo splice mutation (NM_033517.1: c.2265+1G>A) that functionally impairs mRNA splicing, produces multiple splice variants, and results in the reduction of the amounts of mRNA. To analyze the genotype and phenotype correlations for SHANK3 DNMs, we reviewed 37 previously published patients with 28 SHANK3 DNMs. Our results revealed that haploinsufficiency of SHANK3 causes a broad spectrum of neurodevelopmental phenotypes with impaired social interaction, repetitive behavior, speech impairment, ID, and regression as the most common observations. Seizures, hypotonia, global development delay, dysmorphic features, and several other features also occurred recurrently. Specific phenotypes are also observed in certain genotypes. Our study provides the frequency of the heterogeneous co-occurring conditions caused by SHANK3 DNMs, which will be beneficial for diagnosis and clinical management.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990SHANK3; ASD; clinical phenotype; de novo mutation; splice mutation

Mesh:

Substances:

Year:  2018        PMID: 30537371     DOI: 10.1002/ajmg.a.40666

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  8 in total

1.  The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders.

Authors:  Anna Alkelai; Lior Greenbaum; Anna R Docherty; Andrey A Shabalin; Gundula Povysil; Ayan Malakar; Daniel Hughes; Shannon L Delaney; Emma P Peabody; James McNamara; Sahar Gelfman; Evan H Baugh; Anthony W Zoghbi; Matthew B Harms; Hann-Shyan Hwang; Anat Grossman-Jonish; Vimla Aggarwal; Erin L Heinzen; Vaidehi Jobanputra; Ann E Pulver; Bernard Lerer; David B Goldstein
Journal:  Mol Psychiatry       Date:  2021-11-19       Impact factor: 13.437

2.  Strong evidence for genotype-phenotype correlations in Phelan-McDermid syndrome: results from the developmental synaptopathies consortium.

Authors:  Tess Levy; Jennifer H Foss-Feig; Catalina Betancur; Paige M Siper; Maria Del Pilar Trelles-Thorne; Danielle Halpern; Yitzchak Frank; Reymundo Lozano; Christina Layton; Bari Britvan; Jonathan A Bernstein; Joseph D Buxbaum; Elizabeth Berry-Kravis; Craig M Powell; Siddharth Srivastava; Mustafa Sahin; Latha Soorya; Audrey Thurm; Alexander Kolevzon
Journal:  Hum Mol Genet       Date:  2022-02-21       Impact factor: 5.121

3.  Identifying and Exploring the Candidate Susceptibility Genes of Cirrhosis Using the Multi-Tissue Transcriptome-Wide Association Study.

Authors:  Xiao-Bo Zhu; Yu-Qing Hou; Xiang-Yu Ye; Yi-Xin Zou; Xue-Shan Xia; Sheng Yang; Peng Huang; Rong-Bin Yu
Journal:  Front Genet       Date:  2022-05-13       Impact factor: 4.772

4.  Two Genetic Mechanisms in Two Siblings with Intellectual Disability, Autism Spectrum Disorder, and Psychosis.

Authors:  Yu-Shu Huang; Ting-Hsuan Fang; Belle Kung; Chia-Hsiang Chen
Journal:  J Pers Med       Date:  2022-06-20

5.  Gene discoveries in autism are biased towards comorbidity with intellectual disability.

Authors:  Matthew Jensen; Corrine Smolen; Santhosh Girirajan
Journal:  J Med Genet       Date:  2020-03-09       Impact factor: 6.318

6.  Targeted sequencing and integrative analysis to prioritize candidate genes in neurodevelopmental disorders.

Authors:  Yi Zhang; Tao Wang; Yan Wang; Kun Xia; Jinchen Li; Zhongsheng Sun
Journal:  Mol Neurobiol       Date:  2021-04-15       Impact factor: 5.590

Review 7.  The potential of induced pluripotent stem cells for discriminating neurodevelopmental disorders.

Authors:  Ricarda Stock; Pauline Jeckel; Udo Kraushaar; Richard Wüst; Andreas Fallgatter; Hansjürgen Volkmer
Journal:  Stem Cells Transl Med       Date:  2020-08-31       Impact factor: 6.940

8.  Phenotypic Variability in Phelan-McDermid Syndrome and Its Putative Link to Environmental Factors.

Authors:  Luigi Boccuto; Andrew Mitz; Ludovico Abenavoli; Sara M Sarasua; William Bennett; Curtis Rogers; Barbara DuPont; Katy Phelan
Journal:  Genes (Basel)       Date:  2022-03-17       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.